Kyle J. Popovich, MD, MS; Shannon Davila, MSN, RN, CIC, CPHQ; Vineet Chopra, MD, MSc; Payal K. Patel, MD, MPH; Shelby Lassiter, BSN, RN, CPHQ; Russell N. Olmsted, MPH, CIC; David P. Calfee, MD, MS
Disclaimer: The findings and conclusions in this report are those of the authors and do not represent the official position of the CDC, the American Hospital Association, or the Department of Veterans Affairs.
Acknowledgment: The authors thank the Health Research & Educational Trust (HRET) Health Care-Associated Infection team, as well as the National Program Team and all members of the CDC STRIVE collaborative.
Disclosures: Dr. Popovich reports personal fees from the CDC contract with the HRET during the conduct of the study. Ms. Davila and Ms. Lassiter report a CDC contract with HRET during the conduct of the study. Dr. Chopra and Dr. Patel report a contract from the CDC with the HRET, which subcontracted with the University of Michigan to support faculty/staff effort for this contract, during the conduct of the study. Mr. Olmsted reports personal fees from the HRET during the conduct of the study and personal fees from Ethicon outside the submitted work. Dr. Calfee reports a CDC contract with the HRET, which subcontracted with Weill Cornell Medical College, during the conduct of the study. Authors not named here have disclosed no conflicts of interest. Disclosures can also be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M18-3468.
Editors' Disclosures: Christine Laine, MD, MPH, Editor in Chief, reports that her spouse has stock options/holdings with Targeted Diagnostics and Therapeutics. Darren B. Taichman, MD, PhD, Executive Editor, reports that he has no financial relationships or interests to disclose. Cynthia D. Mulrow, MD, MSc, Senior Deputy Editor, reports that she has no relationships or interests to disclose. Jaya K. Rao, MD, MHS, Deputy Editor, reports that she has stock holdings/options in Eli Lilly and Pfizer. Catharine B. Stack, PhD, MS, Deputy Editor, Statistics, reports that she has stock holdings in Pfizer, Johnson & Johnson, and Colgate-Palmolive. Christina C. Wee, MD, MPH, Deputy Editor, reports employment with Beth Israel Deaconess Medical Center. Sankey V. Williams, MD, Deputy Editor, reports that he has no financial relationships or interests to disclose. Yu-Xiao Yang, MD, MSCE, Deputy Editor, reports that he has no financial relationships or interest to disclose.
Corresponding Author: Kyle J. Popovich, MD, MS, Rush University, 600 South Paulina, Suite 143, Chicago, IL 60612; e-mail, Kyle_popovich@rush.edu.
Current Author Addresses: Dr. Popovich: Rush University, 600 South Paulina, Suite 143, Chicago, IL 60612.
Dr. Chopra: Department of Internal Medicine, University of Michigan, 2800 Plymouth Road, Building 16, Room 430W, Ann Arbor, MI 48109-2800.
Ms. Davila: New Jersey Hospital Association, 760 Alexander Road, P.O. Box 1, Princeton, NJ 08543.
Dr. Patel: VA Ann Arbor Healthcare System, 111-I, 2215 Fuller Road, Ann Arbor, MI 48105.
Ms. Lassiter: Center for Health Innovation, American Hospital Association, 155 North Wacker Drive, Suite 400, Chicago, IL 60606.
Mr. Olmsted: Integrated Clinical Services, Trinity Health, 20555 Victor Parkway, Livonia, MI 48152.
Dr. Calfee: Weill Cornell Medicine, 525 East 68th Street, Box 265, New York, NY 10065.
Author Contributions: Conception and design: K.J. Popovich, S. Davila, V. Chopra, P.K. Patel, R.N. Olmsted, D.P. Calfee.
Analysis and interpretation of the data: K.J. Popovich, P.K. Patel, R.N. Olmsted, D.P. Calfee.
Drafting of the article: K.J. Popovich, S. Davila, V. Chopra, D.P. Calfee.
Critical revision of the article for important intellectual content: K.J. Popovich, S. Davila, V. Chopra, P.K. Patel, R.N. Olmsted, D.P. Calfee.
Final approval of the article: K.J. Popovich, S. Davila, V. Chopra, P.K. Patel, S. Lassiter, R.N. Olmsted, D.P. Calfee.
Obtaining of funding: V. Chopra.
Administrative, technical, or logistic support: S. Lassiter.
Collection and assembly of data: S. Davila, V. Chopra.
MRSA bacteremia tier 1 and 2 interventions.
GPS = guide to patient safety; HO = hospital-onset; MRSA = methicillin-resistant Staphylococcus aureus; NHSN = National Healthcare Safety Network.
Popovich KJ, Davila S, Chopra V, et al. A Tiered Approach for Preventing Methicillin-Resistant Staphylococcus aureus Infection. Ann Intern Med. 2019;171:S59–S65. doi: https://doi.org/10.7326/M18-3468
Download citation file:
Published: Ann Intern Med. 2019;171(7_Supplement):S59-S65.
Infectious Disease, MRSA.
Results provided by:
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use